Alivus Life

72
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,434.15
-15.7 (-1.08%)
BSENSE

Nov 20

BSE+NSE Vol: 1.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 6.91% vs 4.54% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 16.80% vs 1.24% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 122.54% vs 56.14% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 16.24% vs 3.13% in Mar 2025

Compare Profit and Loss Results of Alivus Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,551.00
597.00
1,954.00
327.30%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,551.00
597.00
1,954.00
327.30%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-3.00
6.00
200.00%
Raw Materials Consumed
1,063.00
228.00
835.00
366.23%
Power & Fuel Cost
113.00
18.00
95.00
527.78%
Employee Cost
272.00
110.00
162.00
147.27%
Operating Expenses
173.00
21.00
152.00
723.81%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
56.00
17.00
39.00
229.41%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
39.00
-28.00
67.00
239.29%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,754.00
441.00
1,313.00
297.73%
Operating Profit (PBDIT) excl Other Income
797.00
155.00
642.00
414.19%
Other Income
60.00
38.00
22.00
57.89%
Operating Profit (PBDIT)
857.00
193.00
664.00
344.04%
Interest
5.00
10.00
-5.00
-50.00%
Profit before Depriciation and Tax
852.00
183.00
669.00
365.57%
Depreciation
75.00
55.00
20.00
36.36%
Profit Before Taxation & Exceptional Items
776.00
128.00
648.00
506.25%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
751.00
148.00
603.00
407.43%
Provision for Tax
186.00
15.00
171.00
1,140.00%
Profit After Tax
564.00
132.00
432.00
327.27%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,777.00
1,375.00
402.00
29.24%
Profit Available for appropriations
2,341.00
1,508.00
833.00
55.24%
Appropriations
2,341.00
1,508.00
833.00
55.24%
Equity Dividend (%)
250%
60%
190.00
Earnings Per Share
45.99
6.8
39.19
576.32%
Profit And Loss - Net Sales
Net Sales 2,551.83 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.91% vs 4.54% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 797.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.80% vs 1.24% in Mar 2025

Profit And Loss - Interest
Interest 5.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 122.54% vs 56.14% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 564.48 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.24% vs 3.13% in Mar 2025